Hypercholesterolemia, and/or activation or damage of the aged and diseased vessel wall, may hamper successful delivery to or processing of the LNP-siRNA in the endothelial compartment and subsequent silencing of Vwf. Here, VWF is linked to Hypercholesterolemia.